Methods Ethical approval and informed consent were waived as this study utilized publicly available, de-identified data from the FAERS database
Additionally, it also enhances insulin secretion and lowers glucagon levels, which can improve blood sugar control and aid in weight loss
These benefits are reflected in the clinical guidelines published by the American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE), which recommend use of a GLP-1RA or a sodium-glucose co-transporter-2 inhibitor (SGLT2i) with demonstrated CV risk reduction in patients with established/high risk of atherosclerotic CVD (ASCVD), while considering patient-specific factors [15, 17]
Should you microdose a GLP-1
For more information, click the link above #glp1 #ozempic #cat #fatcat #abc7news original sound ABC7 News From a broader scientific perspective, the trial reflects a growing recognition that pet obesity mirrors many of the same structural problems seen in human metabolic health